FREWITT SA, located in Granges-Paccot, Switzerland, and HEMOFARM d.o.o., headquartered in Vr拧ac, Serbia, are pleased to announce another successful collaboration in gentle milling of products as well as fine milling of hard products; notably, with Hemofarm鈥檚 acquisition of an oscillating and rotating sieve mills and a Hammermill type FlexMill HW-6.
鈥淲e’re delighted that our machines can meet Hemofarm’s needs. Even more so as their quality and innovation needs are at the cutting edge of technology. This acquisition confirms the high standard of our machines and the confidence they place in the Frewitt鈥檚 FlexMill range,鈥� announced FREWITT鈥檚 Commercial Director, Roy Housh.
鈥淚t goes without saying that Hemofarm, as a modern and responsible company, follows the guiding principles of sustainable development, with the safety of its employees, and even more so of its products, at heart. Frewitt FlexMills are suitable for milling of products that are heat-sensitive and difficult to process. Because they guarantee optimum milling results in the fine milling and pulverization of hard, crystalline, and fibrous products to fineness of up to 30渭m, they are perfectly in line with our standards,鈥� stated Ivan Djokic Hemofarm鈥檚 PU head of SDF plant Vrsac.
Learn more about FREWITT SA
Benefiting from over 75 years of experience in the grinding and milling of powders, Frewitt has established itself over time as a leader in this field by constantly anticipating the needs of its markets, including Pharmaceuticals, Fine Chemicals, Foods and Energy, and developing its machinery and processes accordingly. Its worldwide presence 鈥� a Global HQ in Switzerland, branch offices in the USA, Germany, China and India, and local representation in over 50 countries 鈥� enables FREWITT to be as close as possible to its customers.
Learn more about Hemofarm
Leader of the pharmaceutical market in Serbia, Hemofarm has operations in three countries (four sites) and sells products in four continents. Established in 1960, Hemofarm manufactures high-quality, effective, safe and affordable pharmaceutical products.
Innovation is a constant at Hemofarm. In addition to researching and developing modern pharmaceutical products, Hemofarm is committed to sustainable development. Its activities comply with the BSCI code of social responsibility and respect for human rights, with one of the most advanced levels of compliance of any company operating in Serbia.